The Nrf2 pathway in liver diseases

J Zhou, Q Zheng, Z Chen - Frontiers in Cell and Developmental …, 2022 - frontiersin.org
Oxidative stress is the leading cause of most liver diseases, such as drug-induced liver
injury, viral hepatitis, and alcoholic hepatitis caused by drugs, viruses, and ethanol. The …

Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease

Y Ma, G Lee, SY Heo, YS Roh - Antioxidants, 2021 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, and scientific studies consistently report that NAFLD development can be …

Oxidative stress and NRF2/KEAP1/ARE pathway in diabetic kidney disease (DKD): new perspectives

DM Tanase, EM Gosav, MI Anton, M Floria… - Biomolecules, 2022 - mdpi.com
Diabetes mellitus (DM) is one of the most debilitating chronic diseases worldwide, with
increased prevalence and incidence. In addition to its macrovascular damage, through its …

Role of oxidative stress in liver disorders

L Conde de la Rosa, L Goicoechea, S Torres… - Livers, 2022 - mdpi.com
Oxygen is vital for life as it is required for many different enzymatic reactions involved in
intermediate metabolism and xenobiotic biotransformation. Moreover, oxygen consumption …

[HTML][HTML] Melatonin alleviates particulate matter-induced liver fibrosis by inhibiting ROS-mediated mitophagy and inflammation via Nrf2 activation

L Zhu, Q Zhang, C Hua, X Ci - Ecotoxicology and Environmental Safety, 2023 - Elsevier
Objective Fine particulate matter (PM2. 5) is a source of pollution worldwide, that causes
inflammation and liver fibrosis. Melatonin, as the predominant hormone secreted by the …

The functional role of sulforaphane in intestinal inflammation: a review

LY Wei, JK Zhang, L Zheng, Y Chen - Food & Function, 2022 - pubs.rsc.org
Intestinal inflammation represented by inflammatory bowel disease (IBD) has become a
global epidemic disease and the number of patients with IBD continues to increase. This …

NLRP3 inflammasome in hepatic diseases: A pharmacological target

E Ramos-Tovar, P Muriel - Biochemical Pharmacology, 2023 - Elsevier
The NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome pathway is
mainly responsible for the activation and release of a cascade of proinflammatory mediators …

Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches

E Conte - Pharmacology & Therapeutics, 2022 - Elsevier
Over almost 140 years since their identification, the knowledge about macrophages has
unbelievably evolved. The'big eaters' from being thought of as simple phagocytic cells have …

[HTML][HTML] Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia

R Wang, M Halimulati, X Huang, Y Ma, L Li… - Journal of Advanced …, 2023 - Elsevier
Introduction Currently, revealing how to prevent and control hyperuricemia has become an
essential public health issue. Sulforaphane has a wide range of applications in the …

NLRP3 inflammasome and pyroptosis in liver pathophysiology: The emerging relevance of Nrf2 inducers

L Hurtado-Navarro, D Angosto-Bazarra, P Pelegrín… - Antioxidants, 2022 - mdpi.com
Inflammasomes, particularly the nucleotide-binding oligomerization domain, leucine-rich
repeat, and pyrin domain containing 3 (NLRP3) inflammasome, apparently serve as crucial …